Piperazine

Piperazine

SCHEMBL1699696

C1CNCCN1.c1ccncc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.60
NAPRT Q6XQN6 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
HIF1A Q16665 1/20 0.40
MAPT P10636 1/20 0.40
PDE4A P27815 1/20 0.40
KDR P35968 1/20 0.40
PLD1 Q13393 2/20 0.37
ADRB2 P07550 1/20 0.37
NCF1 P14598 1/20 0.37
CHRNB2 P17787 4/20 0.34
CHRNA4 P43681 4/20 0.34
CXCR4 P61073 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC6A4 P31645 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
NOTUM Q6P988 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL27982866 1.00 TSHR (0.60) TSHRNAPRTTDP1HIF1AMAPT
Piperazine SCHEMBL28156489 1.00 TSHR (0.60) TSHRNAPRTTDP1HIF1AMAPT
Piperazine SCHEMBL27917020 1.00 TSHR (0.60) TSHRNAPRTTDP1HIF1AMAPT
Piperazine SCHEMBL23911270 0.97 TSHR (0.56) TSHRNAPRTTDP1HIF1AMAPT
Piperazine SCHEMBL28833305 0.97 TSHR (0.56) TSHRNAPRTTDP1HIF1AMAPT
Piperazine SCHEMBL28270001 0.97 TSHR (0.56) TSHRNAPRTTDP1HIF1AMAPT
Pyridine SCHEMBL11825162 0.97
Piperazine SCHEMBL28224527 0.94 TSHR (0.53) TSHRNAPRTTDP1HIF1AMAPT
Piperazine SCHEMBL28144608 0.94 TSHR (0.53) TSHRNAPRTTDP1HIF1AMAPT
Piperazine SCHEMBL28269434 0.94 TSHR (0.53) TSHRNAPRTTDP1HIF1AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113121424-A Continuous reaction for preparing piperazine pyridine compound 浙江瑞博制药有限公司 2021-07-16 CN claimed
CN-112915811-A Composite filter membrane and preparation method thereof 南京理工大学 2021-06-08 CN claimed
CN-110452200-A Heterocyclic compound and organic light emitting apparatus comprising the heterocyclic compound SAMSUNG DISPLAY CO LTD 2019-11-15 CN claimed
CN-108822082-A A kind of fluorine-containing pyridine piperazine acidamide compound and its application 青岛科技大学 2018-11-16 CN claimed
CN-106519210-B A kind of covalent organic polymer and its preparation method and application 苏州大学 2018-11-02 CN claimed
CN-108203539-A Automobile-use interior trim or exterior trim component and shipboard component 铃木株式会社 2018-06-26 CN claimed
CN-103631093-B The manufacture method of the organic light-emitting display device of photoresist and the use photoresist 乐金显示有限公司 2018-03-20 CN claimed
CN-107735426-A Low viscosity transparent polyamide 汉高知识产权控股有限责任公司 2018-02-23 CN claimed
CN-105315298-B A D A conjugated molecules and its preparation method and application based on seven and condensed ring unit 中国科学院化学研究所 2017-10-10 CN claimed
CN-106543108-A A kind of industrialized process for preparing of 3 propyIoxirane, 2 carbonyl ring propionic acid amide. 成都丽凯手性技术有限公司 2017-03-29 CN claimed
CN-104059046-A Flavonoid derivative and application thereof JIANGSU NHWA PHARMACEUTICAL CO LTD 2014-09-24 CN claimed
CN-104013626-A Application of pyridine-piperazine compounds to prepare anti-HIV-1 medicines UNIV SUN YAT SEN 2014-09-03 CN claimed
CN-103992338-A Copper complex based on dipyridine piperazine ligand and Anderson type polyacid, and synthetic method and application thereof UNIV BOHAI 2014-08-20 CN claimed
CN-102702076-B Compound for preparing alvimopan and preparation process and application thereof JIANGSU NHWA PHARMACEUTICAL CO LTD 2014-06-04 CN claimed
CN-1660184-B Combination of medicaiton containing extractive of herb of glabrous sarcandra, and preparation method and application QI CHEN 2010-12-08 CN claimed
CN-100577663-C Fused heterocyclic kinase inhibitors BRISTOL MYERS SQUIBB CO 2010-01-06 CN claimed
CN-100575341-C The derivative of tetrahydro-indolone and the derivative of tetrahydro-indazolone and their application GUOYAO LONGLI BIOLOG MEDICAL NEW TECHNOLOGY CO LTD BEIJING 2009-12-30 CN claimed
CN-101481353-A Tetrahydro indazolone or tetrahydro indolone substituted indazole derivative and salt thereof BEIJING GYLONGLY BIOMEDTECH LT (CN) 2009-07-15 CN claimed
CN-1896060-A Tetrahydro-indolone and tetrahydro-indazolone derivatives and their use GUOYAO LONGLI BIOLOG MEDICAL N (CN) 2007-01-17 CN claimed
CN-1660184-A Combination of medicaiton containing extractive of herb of glabrous sarcandra, and preparation method and application XU GUOLIANG (CN) 2005-08-31 CN claimed